ACADIA Pharmaceuticals, Inc. (ACAD)

23.99 -0.34 (-1.40%) USD  |  NASDAQ  |  Feb 20, 16:00
24.40 +0.41 (+1.71%) Pre-Market: 20:00
More

ACADIA Pharmaceuticals Net Common Equity Issued (Purchased) (Quarterly)

Net Common Equity Issued (Purchased) (Quarterly) Chart

View Net Common Equity Issued (Purchased) (Quarterly) for ACAD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Quarterly) Benchmarks

View Net Common Equity Issued (Purchased) (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
Dynavax Technologies Corp. (DELISTED) Upgrade
Axsome Therapeutics, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade